Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 cell counts have higher mortality than the general population is unknown. We aimed to examine this by analysis of pooled data from industrialised countries
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
International audienceTo identify the risk factors associated with presentation for care with CD4 ce...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Summary Background Whether people living with HIV who have not received antiretroviral therapy (ART)...
BACKGROUND: Whether people living with HIV who have not received antiretroviral therapy (ART) and ha...
BACKGROUND: Whether people living with HIV who have not received antiretroviral therapy (ART) and ha...
Background Mortality in HIV-infected patients has declined substantially with combination antiretrov...
Background: Using data from a large European collaborative study, we aimed to identify the circumsta...
BACKGROUND: Using data from a large European collaborative study, we aimed to identify the circumst...
BACKGROUND: Using data from a large European collaborative study, we aimed to identify the circumsta...
Background: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretrovira...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
International audienceTo identify the risk factors associated with presentation for care with CD4 ce...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Summary Background Whether people living with HIV who have not received antiretroviral therapy (ART)...
BACKGROUND: Whether people living with HIV who have not received antiretroviral therapy (ART) and ha...
BACKGROUND: Whether people living with HIV who have not received antiretroviral therapy (ART) and ha...
Background Mortality in HIV-infected patients has declined substantially with combination antiretrov...
Background: Using data from a large European collaborative study, we aimed to identify the circumsta...
BACKGROUND: Using data from a large European collaborative study, we aimed to identify the circumst...
BACKGROUND: Using data from a large European collaborative study, we aimed to identify the circumsta...
Background: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretrovira...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
International audienceTo identify the risk factors associated with presentation for care with CD4 ce...